Concorde Asset Management, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Concorde Asset Management, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$3,223,000
+154.8%
73,982
+157.8%
2.14%
+183.6%
Q4 2021$1,265,000
+29.3%
28,693
+12.1%
0.76%
+33.9%
Q3 2021$978,000
-69.2%
25,598
-67.9%
0.56%
-68.4%
Q2 2021$3,176,000
+96.4%
79,765
+76.1%
1.78%
+91.3%
Q1 2021$1,617,00045,3020.93%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2022
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders